PDGFRB promotes dedifferentiation and pulmonary metastasis through rearrangement of cytoskeleton under hypoxic microenvironment in osteosarcoma
- Enjie Xu 1, Zhen Huang 1, Kunpeng Zhu 1, Jianping Hu 1, Xiaolong Ma 1, Yongjie Wang 1, Jiazhuang Zhu 1, Chunlin Zhang 1
- Enjie Xu 1, Zhen Huang 1, Kunpeng Zhu 1
- 1Department of Orthopedic Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China; Institute of Bone Tumor Affiliated to Tongji University School of Medicine, Shanghai 200072, PR China.
- 0Department of Orthopedic Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, PR China; Institute of Bone Tumor Affiliated to Tongji University School of Medicine, Shanghai 200072, PR China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hypoxia promotes osteosarcoma dedifferentiation and metastasis. Hypoxia inducible factor 1 subunit alpha (HIF1A) upregulates platelet derived growth factor receptor beta (PDGFRB), driving cancer cell changes and spread.
Area Of Science
- Oncology
- Cell Biology
- Molecular Biology
Background
- Osteosarcoma (OS) frequently exhibits hypoxia and dedifferentiation, correlating with poor patient outcomes.
- Understanding the molecular mechanisms linking hypoxia to OS dedifferentiation is critical for improving treatment strategies.
Purpose Of The Study
- To elucidate the role of hypoxia in osteosarcoma dedifferentiation.
- To identify key signaling pathways involved in hypoxia-induced OS dedifferentiation and metastasis.
Main Methods
- Sphere formation assays to identify dedifferentiated cells.
- RNA interference (RNAi) to investigate the HIF1A-PDGFRB axis.
- Analysis of signaling molecules (PDGFRB, FAK, RhoA, MLC2) and cytoskeleton dynamics.
- In vitro (wound healing, Transwell) and in vivo (pulmonary metastasis) assays to assess OS cell migration and invasion.
Main Results
- Dedifferentiated OS cells showed elevated HIF1A and PDGFRB expression.
- HIF1A positively regulated PDGFRB, activating RhoA and MLC2 phosphorylation.
- PDGFRB enhanced FAK phosphorylation, altered cell morphology, and promoted actin cytoskeleton rearrangement.
- PDGFRB significantly increased OS cell migration, invasion, and pulmonary metastasis.
Conclusions
- Hypoxia-inducible factor 1 subunit alpha (HIF1A) upregulates platelet-derived growth factor receptor beta (PDGFRB) in hypoxic osteosarcoma.
- PDGFRB signaling, involving RhoA and cytoskeleton modulation, drives OS dedifferentiation and metastasis.
- Targeting the HIF1A-PDGFRB pathway may offer therapeutic potential for osteosarcoma.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:24
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
02:53
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

